[{"NetIncomeLoss_4_FY_USD":3513200000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_FY_USD":200000.0,"CurrentFederalTaxExpenseBenefit_4_FY_USD":199000000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_4_FY_USD":768900000.0,"AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_4_FY_USD":-895100000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-70600000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":29300000.0,"InterestPaidNet_4_FY_USD":23200000.0,"PaymentsForProceedsFromOtherInvestingActivities_4_FY_USD":0.0,"InventoryFinishedGoodsNetOfReserves_0_FY_USD":121700000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_FY_USD":59200000.0,"LongTermDebtFairValue_0_FY_USD":1958000000.0,"CommitmentsAndContingencies_0_FY_USD":null,"MarketableSecuritiesCurrent_0_FY_USD":1393300000.0,"ProvisionForDoubtfulAccounts_4_FY_USD":0.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4_FY_USD":9100000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_4_FY_USD":7200000.0,"FinanceLeaseLiability_0_FY_USD":717200000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_FY_USD":1521800000.0,"OtherNoncashIncomeExpense_4_FY_USD":135000000.0,"Assets_0_FY_USD":17163300000.0,"AvailableForSaleSecuritiesDebtSecurities_0_FY_USD":3689100000.0,"InventoryWorkInProcessNetOfReserves_0_FY_USD":904600000.0,"UnrecognizedTaxBenefits_0_FY_USD":267000000.0,"IncomeTaxesPaidNet_4_FY_USD":188100000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":15100000.0,"TreasuryStockValue_0_FY_USD":6613300000.0,"AssetsCurrent_0_FY_USD":9779100000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_4_FY_USD":2576400000.0,"FinanceLeaseInterestExpense_4_FY_USD":15700000.0,"LossContingencyAccrualAtCarryingValue_0_FY_USD":9600000.0,"TreasuryStockShares_0_FY_shares":16431520.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":723100000.0,"ProceedsFromIssuanceOfLongTermDebt_4_FY_USD":1981900000.0,"FinanceLeaseLiabilityNoncurrent_0_FY_USD":717200000.0,"SellingGeneralAndAdministrativeExpense_4_FY_USD":1346000000.0,"CurrentStateAndLocalTaxExpenseBenefit_4_FY_USD":1200000.0,"DefinedContributionPlanCostRecognized_4_FY_USD":44700000.0,"Liabilities_0_FY_USD":6138000000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":2193700000.0,"EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit_4_FY_pure":0.005,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4_FY_USD":118900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4_FY_USD":1368100000.0,"NumberOfReportableSegments_4_FY_segment":1.0,"IncomeTaxExpenseBenefit_4_FY_USD":297200000.0,"LesseeFinanceLeaseDiscountRate_0_FY_pure":0.0166,"AccountsReceivableNetCurrent_0_FY_USD":3111500000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_FY_USD":2295800000.0,"OtherNonoperatingIncomeExpense_4_FY_USD":290700000.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0_FY_USD":139800000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_4_FY_USD":196000000.0,"InventoryWriteDown_4_FY_USD":39200000.0,"EarningsPerShareBasic_4_FY_USD":32.65,"EarningsPerShareBasic_1_FY_USD":10.9,"ValuationAllowancesAndReservesDeductions_4_FY_USD":968800000.0,"ResearchAndDevelopmentExpense_4_FY_USD":2735000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":115100000.0,"DepreciationDepletionAndAmortization_4_FY_USD":235900000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_4_FY_pure":0.076,"EffectiveIncomeTaxRateContinuingOperations_4_FY_pure":0.078,"OtherAssetsNoncurrent_0_FY_USD":168100000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_FY_USD":1131100000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":3521400000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":12100000.0,"AccruedLiabilitiesAndOtherLiabilities_0_FY_USD":1521800000.0,"IncreaseDecreaseInInventories_4_FY_USD":529400000.0,"FinanceLeaseLiabilityPaymentsDue_0_FY_USD":735200000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_4_FY_USD":3785000000.0,"RestrictedCash_0_FY_USD":13600000.0,"CostsAndExpenses_4_FY_USD":4920500000.0,"CostsAndExpenses_1_FY_USD":1255900000.0,"ValuationAllowancesAndReservesChargedToOtherAccounts_4_FY_USD":1136900000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_4_FY_USD":-2000000.0,"FinanceLeaseLiabilityPaymentsDueYearFive_0_FY_USD":0.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_0_FY_USD":436600000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_FY_USD":4352700000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":-1970500000.0,"ShareBasedCompensation_4_FY_USD":432000000.0,"OtherOperatingIncomeExpenseNet_4_FY_USD":280400000.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.01,"DeferredIncomeTaxAssetsNet_0_FY_USD":858900000.0,"AccountsPayableCurrent_0_FY_USD":475500000.0,"LiabilitiesCurrent_0_FY_USD":2697400000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_4_FY_pure":-0.007,"RepaymentsOfShortTermDebt_4_FY_USD":1500000000.0,"MarketableSecuritiesNoncurrent_0_FY_USD":3135600000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_FY_USD":1393300000.0,"PaymentsToAcquireProductiveAssets_4_FY_USD":614600000.0,"NonoperatingIncomeExpense_4_FY_USD":233800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":107600000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":2618100000.0,"ValuationAllowancesAndReservesBalance_0_FY_USD":324200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":442900000.0,"ProceedsFromShortTermDebt_4_FY_USD":1500000000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4_FY_USD":680800000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_FY_USD":40100000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4_FY_USD":8200000.0,"InventoryRawMaterialsNetOfReserves_0_FY_USD":459400000.0,"DeferredFederalIncomeTaxExpenseBenefit_4_FY_USD":109000000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_4_FY_pure":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":2207300000.0,"NetIncomeLoss_1_FY_USD":1149200000.0,"OtherInventoryNetOfReserves_0_FY_USD":430900000.0,"CapitalExpendituresIncurredButNotYetPaid_4_FY_USD":83600000.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"EffectiveIncomeTaxRateReconciliationTaxCredits_4_FY_pure":0.028,"AdditionalPaidInCapital_0_FY_USD":6716200000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_FY_USD":0.0,"InterestExpense_4_FY_USD":56900000.0,"IncreaseDecreaseInDeferredIncomeTaxes_4_FY_USD":-75600000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"FinanceLeaseLiabilityPaymentsDueYearThree_0_FY_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":329600000.0,"LongTermDebtNoncurrent_0_FY_USD":1978500000.0,"EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_4_FY_pure":-0.018,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4_FY_USD":76600000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":160800000.0,"FinanceLeaseRightOfUseAssetAmortization_4_FY_USD":14400000.0,"PaymentsToAcquireMarketableSecurities_4_FY_USD":3241000000.0,"EarningsPerShareDiluted_1_FY_USD":10.24,"EarningsPerShareDiluted_4_FY_USD":30.52,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":465800000.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":17163300000.0,"DeferredIncomeTaxExpenseBenefit_4_FY_USD":75600000.0,"PreferredStockValue_0_FY_USD":0.0,"FinanceLeaseLiabilityPaymentsDueAfterYearFive_0_FY_USD":0.0,"StockRepurchasedDuringPeriodValue_4_FY_USD":5880900000.0,"InventoryNet_0_FY_USD":1916600000.0,"PreferredStockSharesAuthorized_0_FY_shares":30000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4_FY_USD":-900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4_FY_USD":3810400000.0,"OperatingIncomeLoss_4_FY_USD":3576600000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_FY_USD":2422900000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":8497100000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":-114900000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_FY_USD":3221600000.0,"DeferredTaxAssetsNet_0_FY_USD":761500000.0,"PaymentsForRepurchaseOfCommonStock_4_FY_USD":5846800000.0,"FinanceLeaseRightOfUseAsset_0_FY_USD":645700000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":0.0,"DeferredTaxLiabilitiesOther_0_FY_USD":42800000.0,"DeferredTaxAssetsGross_0_FY_USD":761500000.0,"CurrentForeignTaxExpenseBenefit_4_FY_USD":21400000.0,"IncreaseDecreaseInAccountsReceivable_4_FY_USD":1356100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":577000000.0,"CurrentIncomeTaxExpenseBenefit_4_FY_USD":221600000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":10893000000.0,"TaxesPayableCurrent_0_FY_USD":19500000.0,"DeferredForeignIncomeTaxExpenseBenefit_4_FY_USD":-31400000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4_FY_USD":2442300000.0,"FinanceLeaseRightOfUseAssetAccumulatedAmortization_0_FY_USD":90500000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":3649200000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_FY_USD":0.0,"DeferredTaxAssetsDeferredIncome_0_FY_USD":44600000.0,"StockholdersEquity_0_FY_USD":11025300000.0,"OtherLiabilitiesCurrent_0_FY_USD":122400000.0,"DeferredTaxAssetsPropertyPlantAndEquipment_0_FY_USD":140500000.0,"DeferredTaxAssetsLiabilitiesNet_0_FY_USD":718700000.0,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":2575200000.0,"IncreaseDecreaseInContractWithCustomerLiability_4_FY_USD":148100000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210208"}]